Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes

Author:

Elsabah Hesham1,Ghasoub Rola2ORCID,Soliman Dina S.345,Ibrahim Feryal3,Aldapt Mahmood B.6,Taha Ruba Y.1,Al Azawi Safaa1,Mudawi Deena1,Moustafa Abbas7,Elomri Halima1,Cherif Honar18

Affiliation:

1. Division of Hematology, Department of Medical Oncology National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC) Doha Qatar

2. Department of Pharmacy National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC) Doha Qatar

3. Department of Laboratory Medicine and Pathology National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC) Doha Qatar

4. Department of Laboratory Medicine and Pathology Weill Cornell Medical College (WCMC‐Q) Doha Qatar

5. Department of Clinical Pathology National Cancer Institute Cairo Egypt

6. Internal Medicine Unity hospital, Rochester Regional Health Rochester New York USA

7. Department of Radiology National Center for Cancer Care & Research (NCCCR), Hamad Medical Corporation (HMC) Doha Qatar

8. Faculty of Medicine College of Medicine, Qatar University Doha Qatar

Abstract

AbstractBackgroundPlasmacytoma of the skull base is a rare manifestation of plasma cell neoplasm with only a few cases documented in literature involving young adults. Plasmacytoma can be an isolated solitary lesion or a secondary manifestation of multiple myeloma (MM). In this study, we report the clinical and radiological characteristics, management, and outcomes of patients under the age of 40 who presented with skull base plasmacytoma and associated neurological manifestations. Additionally, we share our experience in treating a rare case of skull base plasmacytoma diagnosed during pregnancy, in which the patient exhibited a favorable response to myeloma treatment initiated after delivery.Case SeriesFour patients were identified, comprising one pregnant female and three male patients, with a median age of 36 years (range 33–37 years). The main presenting symptoms were headache, dizziness, and cranial nerve palsy. All patients received underwent systemic myeloma therapy and radiotherapy with three patients also underwent autologous stem cell transplantation (ASCT). Notably, all patients achieved complete remission.ConclusionSkull base plasmacytoma represents a rare manifestation of plasma cell neoplasms, underscoring the importance of considering it in the differential diagnosis of skull base lesions to ensure early intervention and avoid potential serious complications. Throughout our series, the cornerstone of therapy involved radiotherapy, systemic myeloma therapy, and ASCT, all of which elicited a favorable response in every case.

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3